January 8, 2018 / 1:41 PM / in 10 days

BRIEF-Infinity Expects Net Loss For 2018 To Range From $40 Mln To $50 Mln​

Jan 8 (Reuters) - Infinity Pharmaceuticals Inc:

* INFINITY PHARMACEUTICALS INC - ‍INFINITY EXPECTS NET LOSS FOR 2018 TO RANGE FROM $40 MILLION TO $50 MILLION​

* INFINITY PROVIDES UPDATE ON IPI-549 PHASE 1/1B STUDY, 2018 GOALS AND FINANCIAL GUIDANCE

* INFINITY PHARMACEUTICALS INC - ‍INFINITY EXPECTS TO END 2018 WITH A YEAR-END CASH AND INVESTMENTS BALANCE RANGING FROM $10 MILLION TO $20 MILLION​

* INFINITY PHARMACEUTICALS INC - EXPECTS TO END 2018 WITH A YEAR-END CASH AND INVESTMENTS BALANCE RANGING FROM $10 MILLION TO $20 MILLION

* INFINITY PHARMACEUTICALS INC - ‍INFINITY ENDED 2017 WITH APPROXIMATELY $57.6 MILLION IN CASH AND INVESTMENTS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below